Abstract Deregulated b-adrenoceptor/cAMP-PKA pathway is implicated in a range of human diseases, such as neuronal loss during aging, cardiomyopathy and septic shock. The molecular mechanism of this process is, however, only poorly understood. We recently had demonstrated that the b-adrenoceptor/cAMP-PKA pathway triggers apoptosis through the transcriptional induction of the pro-apoptotic BH3-only Bcl-2 family member BIM in tissues, such as the thymus and the heart. Induction of BIM is driven by the transcriptional co-activator CBP (CREB Binding Protein) together with the proto-oncogene c-Myc. Association of CBP with c-Myc leads to altered histone acetylation and methylation pattern at the BIM promoter site [Lee et al., Cell Death Difference 20(7):941-952 (2013)]. However since CBP is a co-factor for multiple transcription factors, BH-3 only proteins other than Bim could also contribute to this apoptosis pathway. Here we provide evidence for the involvement of p53-CBP axis in apoptosis through Puma/Noxa induction, in response to badrenoceptor activation. Our findings highlight the molecular complexity of pathophysiology associated with a deregulated neuro-endocrine system and for developing novel therapeutic strategies for these diseases.
Introduction
Cyclic adenosine monophosphate (cAMP) is a second messenger conserved throughout evolution. In bacteria, it regulates catabolite repression and quorum sensing [1, 2] whereas in lower forms of eukaryotes such as Dictyostelium, it regulates chemotaxis and differentiation [3] . In metazoans, its primary role is to act as an intracellular carrier of metabolic information, for example regulating hormonal responses [4] and in eliciting apoptotic responses and regulating ontogeny [5, 6] . cAMP-regulated Protein Kinase A (PKA) is the main target of cAMP flux in mammals. Using transgenic mouse models, it is now firmly established that deregulated cAMP/PKA pathway leads to apoptosis [7, 8] .
Aging and chronic stress in humans are associated with marked and sustained increases in the sympathetic nervous system activity in several peripheral tissues, including the heart and thymus [9] . This increased activity produces excess catecholamines, which bind bARs and induce cAMP production [10] . This catecholamine-induced betaadrenergic receptor (bAR) activation or by autoantibodies as seen in Grave's disease [11] could lead to PKA-mediated cardiomyocyte apoptosis resulting in heart failure [12] . bARs also exist on the surface of both B and T cells which are known to affect migration and activation of these lymphocytes [13] . Catecholamines appear to regulate the activity of immunocompetent cells and this could partly explain the immunological privilege status of the central nervous system. In addition, catecholamines such as adrenaline are used in the acute phase of septic shock to improve hemodynamic status of the heart [14] and this is associated with profound alterations in immune cells due to apoptosis [15] . Catecholamine mediated apoptosis is also attributed to the loss of dopamine receptor containing neurons during aging [16] and to stress-induced immune modulation [17] .
The molecular basis of bAR-cAMP/PKA axis in inducing apoptosis is yet to be determined. The BH3-only Bcl-2 family protein Bim is considered to be an essential initiator of apoptosis in a wide variety of physiological settings including calcium flux, growth factor withdrawal [18] , endoplasmic reticulum stress [19] , T cell receptor activation [20] and B cell receptor activation [21] . We had previously reported that the cAMP/PKA pathway has a significant effect on Bim at the protein level [22] . The major isoform of Bim (BimEL) interacts with the regulatory subunit of PKA, PRKAR1A. This complex acts as scaffolding structure that brings the catalytic subunit of PKA (PKACa) in close proximity to BimEL resulting in its phosphorylation. Phosphorylation of Bim by PKA enhances the stability of the protein. Mutations that abolish the phosphorylation result in the rapid turn over of Bim and reduced apoptotic ability.
In S49-T lymphoma cell line, it was shown that Bim was essential for cAMP/PKA activated cell death [23] . The transcriptional induction of BIM was attributed to the transcription factors ATF1 and CREB based on the presence of a cAMP responsive element on the BIM promoter [24] . However, a direct evidence for ATF1/CREB engagement to the BIM promoter is still lacking. We recently had shown that the transcription factor c-Myc and the co-factor CREB binding protein (CBP) are necessary for cAMP/PKA-induced transcriptional regulation of BIM [25] . We also had shown that in cardiomyocytes and in thymocytes, cAMP/PKA-induced apoptosis is Bim dependent. However, these results do not exclude the possibility that other BH3-only proteins may also contribute to this apoptosis pathway. In the present work, we show that PUMA, another BH3-only Bcl-2 family member plays a significant role in regulating cAMP/PKA-induced apoptotic pathway. p53 plays an important role in the transcriptional regulation of PUMA and we provide evidence that during cAMP/PKA activation, the transcriptional induction of PUMA and another BH3-only gene NOXA, involves an interplay between CREB binding protein (CBP) and p53.
Materials and methods
Cell culture, transfection, lentiviral/retroviral infection Mouse embryonic fibroblasts (MEFs) and LK-2 cells were cultured in DMEM supplemented with 10 % fetal calf serum (Invitrogen, Carsbad, USA) at 37°C in a humidified 10 % CO2 incubator. Wild type and various knock-out MEFs were generated from E15 embryos in accordance with standard procedures and were infected with SV40 large T antigen expressing lentivirus. To generate lentiviral particles, 293T cells were transfected with packaging constructs pCMV ðR8.2 and VSV g and the relevant lentiviral plasmid at a ratio of 1:0.4:0.6 using Fugene 6.0TM transfection reagent (Promega corporation, Fitchburg, USA) following the manufacturer's instructions. The virus containing supernatants were harvested, filtered (0.8 lM), and supplemented with Polybrene (4 lg/mL). Target cells were infected with virus supernatant as described by Lee et al. [25] .
For retroviral infection, pMSCV based vectors carrying gene of interest were transfected into Phoenix cells using Fugene 6.0TM transfection reagent (Promega Corporation, Fitchburg, USA) following the manufacturer's instructions. The virus containing supernatants were harvested, filtered (0.8 lM), and supplemented with Polybrene (4 lg/mL). Target cells were infected with virus supernatant as described by Gangoda et al. [26] . GFP positive cells were sorted by FACSAria III cell sorter (Becton and Dickinson, NJ, USA).
Cell death analysis
Cells were seeded at density of 5 9 10 4 per well in a 12-well plate and were allowed to adhere for 24 h at 37°C and 10 % CO 2 . These cells were treated with 10 lM dobutamin (Cat# D0676 Sigma, Castle Hill, NSW, Australia) and 10 lM rolipram (Cat# R6520 Sigma, Castle Hill, NSW, Australia) in serum free DMEM medium for 24 and 48 h. The cells were then centrifuged at 1,500 rpm for 5 min and the pellet was resuspended in 100 lL of Annexin-V FITC (1:1,000 in KDSBSS buffer (1.68 M KCl, 1.12 M CaCl 2 , 1.68 M MgSO 4 , and 1.68 M KH2PO 4 ). Following incubation on ice for 30 min the cells were washed with 3.5 mL KDSBSS buffer and centrifuged at 151 g for 5 min, supernatant was discarded and the cells were vortexed briefly followed by addition of 100 lL of propidium iodide (1.2 lg/mL). Samples were analysed by flow cytometry using a FACS-Calibur (BD Biosciences, NJ, USA).
Quantitative PCR Total RNA from MEFS was isolated using TRIZOL Ò . Complementary DNA (cDNA) was synthesized from 2 lg of total RNA using the Superscript III RT-PCR system (Cat# 18080-051 Invitrogen, Carlsbad, USA), using oligodT primer according to manufacturers instructions. qPCR was carried out using Brilliant II SYBER Green QPCR master Mix (Cat# 600828 Stratagene, La Jolla, USA). All cDNA samples were tested in triplicate using a Light cycler Ò 480 Real-time PCR instrument (Roche Applied Science, Penzburg, Germany). Following primers were used for qPCR reactions: BIM (F): GAGTTGTGACAAG TCAACACAAACC; BIM (R): GAAGATAAAGCGTAA CAGTTGTAAGATA; NUR77 (F): CCTGTTGCTAGAG TCTGCCTTC; NUR77 (R): CAATCCAATCACCAAAG CCACG; PUMA (F): ATGCCTGCCTCACCTTCATCT; PUMA (R): AGCACAGGATTCACAGTCTGGA; NOXA (F): ACTGTGGTTCTGGCGCAGAT; NOXA (R): TTGA GCACACTCGTCCTTCAA
Western blot analyses
Western blot analyses were performed as described before [22] . The following antibodies were used: Anti Bim (rat monoclonal 3C5, kind gift from Prof. Andreas Strasser), anti Puma (3043-P, rabbit polyclonal, ProSci, San Diego, CA, USA), anti-p53 (NCL-p53-CM5p, rabbit polyclonal, Leica microsystems, Newcastle, UK), anti-p21 (ab18209, rabbit polyclonal, Abcam, Cambridge, UK), and anti-HSP70 (JG-1, MA3-028, Thermo Scientific, Scoresby VIC, Australia).
Results

PUMA co-operates with BIM in inducing bAR-mediated apoptosis
We had recently demonstrated that in breast cancer epithelial cells (MCF7), primary thymocytes and cardiomyocytes, Bim plays a crucial role in initiating apoptosis in response to bAR activation. The mechanisms involved post-translational stabilization of Bim protein by PKA phosphorylation [22] or the transcriptional induction mediated through the CBP/c-Myc axis, which leads to epigenetic changes at the BIM locus [25] . However, in mouse embryonic fibroblasts (MEFs), though bAR signalling induces BIM, BIM ablation does not protect against bAR signalling-induced apoptosis. This suggested that additional BH3-only proteins play a role in this death pathway. Therefore we used a variety of MEFs, i.e.
BAK -/-DKO MEFs to study their viability following bAR activation. These MEFs were treated with a pan-bAR agonist (Dobutamine [27] ) and the phosphodiesterase inhibitor rolipram. The percentage of viable cells 24 and 48 h after ßAR activation clearly indicates that while BIM and PUMA ablation individually did not offer any protection from apoptosis, their combined ablation resulted in a significant protection. This protection was also seen in p53 knockout cells (Fig. 1a) . Since deletion of BAX and BAK protected the cells almost completely from apoptosis, these data show that the intrinsic mitochondrial apoptotic pathway exclusively regulates this death in a manner dependent on both Bim and Puma and possibly other p53-dependent proteins such as Noxa, and requiring the activation of Bax and Bak. Consistent with this observation, we could see a robust induction of both Bim and Puma in MEFs treated with the pan-bAR agonist Dobutamine (Fig. 1b) .
Transcriptional induction of pro apoptotic genes during cAMP/PKA activation Having established that combined ablation of BIM and PUMA leads to protection from apoptosis, we next examined the transcriptional induction of various pro-apoptotic genes in response to bAR stimulation. Consistent with the apoptotic response, we observed rapid and robust induction of both BIM and PUMA during bAR stimulation. Since p53 ablation offered similar protection to combined BIM and PUMA deletion, we reasoned that other p53 target genes could also be induced. We measured the expression of NOXA, a p53-induced BH3-only protein and observed induction in response to bAR stimulation (Fig. 2a) . NUR77 expression was used as a control, since this gene is also induced by bAR stimulation but is not p53-dependent [28] . Importantly, induced PUMA and NOXA expression was not seen in TP53 -/-MEFs, whereas NUR77 remained bARinducible (Fig. 2b) . These results show that in MEFs, bAR stimulation leads to transcriptional induction of p53 target genes such as PUMA and NOXA.
Role of p53 during bAR activation
Adrenaline has been reported to lead to b-arrestin-mediated regulation of p53 through the activation of bAR-PKA pathway in the thymus [29] . However, the stress response we observed in the thymus is different from MEFs as BIM ablation alone offered complete protection from apoptosis in response to bAR activation in thymus but not in MEFs [25] . Since TP53 deletion offered protection against apoptosis and resulted in reduced transcription of p53 target genes such as PUMA and NOXA, we wanted to further elucidate the role of p53 in bAR-mediated apoptosis. We used a GFP reporter with upstream p53 binding sites (cloned from the PUMA promoter) [30] . Infection of wild type MEFs with the reporter resulted in a strong expression of the GFP reporter in contrast to infection of TP53 -/-MEFs, which had substantially reduced baseline levels of GFP expression (Fig. 3a) . This confirmed that the GFP expression from this reporter was p53-dependent (Fig. 3a) . When these MEFs were treated with bAR agonist, Dobutamine, there was a significant increase in the level of GFP expression in the wild type MEFs and this response was muted in TP53 -/-MEFs suggesting that p53 is activated in response to bAR activation (Fig. 3b) . This finding was corroborated by analysing the expression levels of p21, a downstream target of p53. While wild type MEFs induced p21 protein level during bAR activation, this effect was not observed in TP53 -/-MEFs (Fig. 3c) . It has been reported that bAR activation leads to the down regulation of p53 protein levels in thymocytes [29] . However, this mode of regulation did not appear to be playing any role in p53 regulation in MEFs in response to bAR activation. If this were the case, one would expect the levels of PUMA to be down regulated as well. Indeed, Western blot analysis clearly showed that the steady state levels of p53 remained the same (Fig. 3d) .
Role of CBP in p53-mediated PUMA induction
We had previously shown that the transcriptional co-factor CBP was necessary for c-Myc mediated BIM up regulation during bAR activation [22] . CBP is a histone acetyl transferase that associates with a variety of transcription factors including p53 and FoxO3a [31, 32] . Therefore, we wanted to see if CBP was involved in regulating PUMA expression. To this end we used the lung carcinoma cell line LK-2, which does not have a functional CBP protein owing to a deletion of exon 3 of the CBP gene [33] . We expressed functional FLAG-tagged CBP gene in these cells using 4-hydroxytamoxifen (4-OHT)-inducible lentiviral expression system (Fig. 4, inset) . While the wild type LK-2 cells failed to induce PUMA in response to bAR activation, the LK-2 cells with functional CBP was able to induce PUMA as seen by qPCR analysis (Fig. 4) . Thus these results suggest that during bAR activation, CBP plays a pivotal role in p53-mediated PUMA induction. We further confirmed the relationship between p53 and CBP in the GFP reporter system. Transient transfection of WT MEFs expressing the p53-GFP reporter with a construct encoding wild type CBP consistently gave a shift in fluorescence intensity (in the lower range) whereas similar transfection did not result any shift in fluorescence in TP53 -/-MEFs (Fig. 5) . Moreover, transient transfection of WT MEFs expressing the p53-GFP reporter with a HAT deficient (histone acetyltransferase) mutant CBP [25] did not result in fluorescent shift suggesting that activation of p53 by CBP requires its HAT domain.
Discussion
Increased sympathetic nervous activity in the myocardium is a central feature in patients with heart failure [10] . Aging and chronic stress in humans are associated with marked and sustained increases in the sympathetic nervous system activity in several peripheral tissues such as thymus and heart [9] . This increased activity produces excess catecholamines, which bind bARs and induce cAMP production. Our previous work points to a role of Bim during cAMP-mediated apoptosis of cells in vitro and in acute, chemically induced cardiomyopathy models [25] . Whilst BIM -/-thymocytes and cardiomyocytes were protected against catecholamine-mediated apoptosis [25] in MEFs the protection afforded by deletion of BIM was no greater than in WT cells. Since the protection afforded by deletion of Bax and Bak indicates that the intrinsic apoptosis pathway, regulated by the Bcl-2 protein family is absolutely required for ßAR-induced apoptosis, this suggests that additional Bcl-2 family members are involved in this cell death. Our findings using MEFs derived from genedeleted mice clearly demonstrate that in addition to Bim, Puma contributed to catecholamine-mediated apoptosis, particularly in the earlier phases of apoptosis pathway activation (Fig. 1) . It is also clear that as catecholamine exposure persists beyond 24 h, deletion of Bim and Puma no longer prevents apoptosis, whereas Bax/Bak deletion Fig. 3 does. This may indicate that other BH3-only proteins, such as Noxa, become progressively more important over time, or that anti-apoptotic Bcl-2 family member protein levels decline after the first 48 h. qPCR analysis showed that BIM, PUMA and NOXA were transcriptionally upregulated in response to catecholamine treatment (Fig. 2) . This is similar to the regulation of these pro-apoptotic genes in response to a variety of stress phenomena, including ER stress, growth factor deprivation and gamma-irradiation. In these stress-apoptosis models, p53-dependent transcription plays a key role [30, 34, 35] . Thus our results that TP53 -/-MEFs are protected against catecholamine-induced cell death (Fig. 1) supports the notion that the tumor suppressor protein p53 plays an important role in this cell ßAR-activated death pathway.
A previous report on bAR-mediated stress response had identified a role for p53 in stress-induced DNA damage [29] and highlighted a mechanism in which b-adrenergic catecholamines, acting through b-arrestin-mediated signalling pathways, suppressed p53 protein levels. Although we could clearly demonstrate bAR-mediated activation of p53-dependent transcription using GFP reporter and through its downstream target p21 levels (Fig. 3a, b) , we could not demonstrate any discernable reduction in p53 protein levels (Fig. 3d) . This is consistent with the other reports, which suggested a co-operative binding between p53 and the HAT protein CBP [36] . This association is mediated through the interaction between p53 and the KIX domain of p53, which enhances p53 transcriptional activity. Furthermore, direct acetylation of p53 by CBP is known to contribute to its transcriptional activity [37] . This is supported by our data where enforced CBP expression in cells that lack functional CBP was able to drive Puma mRNA expression (Fig. 4) . Besides, transient expression of WT CBP, not the HAT-deficient CBP, was able to modulate GFP expression from a PUMA promoter in wild type MEFs. These results suggest a direct interlay between CBP and p53 to regulate pro apoptotic protein expression in response to ßAR stimulation. p53 appears to have a differential role in apoptosis induction i.e. in thymocytes and cardiomyocytes it does not play any role and the apoptosis in these cells is mediated solely through CBP-c-Myc-Bim axis [25] , and in other cell types such as MEFs (and possibly in other tissues), CBPp53 axis appears to play a significant role. This discrepancy could be reconciled by the fact that this interaction exists only in selective cell types/tissues. CBP-p53 interaction is a function of p53 phosphorylation status. Multisite phosphorylation represents a mechanism for a graded p53 response, with each successive phosphorylation event resulting in increasingly efficient recruitment of CBP to p53-regulated transcriptional programs, in the face of competition from cellular transcription factors [38] . Multisite phosphorylation of p53 thus acts as a rheostat to enhance binding to CBP and provides a plausible mechanistic explanation for the gradually increasing p53 response observed following prolonged or severe genotoxic stress or differential role of p53 in cAMP/PKA-mediated apoptotic response in different cell types.
In our previous study on the role of Bim in cAMP/PKAmediated apoptosis in thymocytes and cardiomyocytes [25] , we had suggested that blocking Bim induction could prove to be a therapeutic avenue to treat associated diseases such as cardiomyopathy. However, in light of the present observation, blocking Bim induction alone may not be sufficient. The role of Bim may not be universal as pathologies associated with de-regulated catecholamines such as cancer cachexia [39] could have more to do with p53-mediated apoptosis [40] and thus drug developments should be targeted towards breaking the nexus between CBP and p53.
